Navigation Links
Cardica Appoints Christopher Littel VP, Sales and Marketing
Date:10/24/2011

REDWOOD CITY, Calif., Oct. 24, 2011 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today named Christopher J. Littel vice president of sales and marketing. In this role, Mr. Littel will be responsible for the sales and marketing strategy and implementation for Cardica's existing cardiac surgery devices and its planned MicroCutter™ product family, Cardica's cutting and stapling devices for laparoscopic surgery.

"Chris brings experience as a successful medical device executive.  He has worked within an emerging medical technology company and has a deep understanding of the laparoscopic market and relationships with many of the key opinion leaders in this field from his time leading the Ethicon Endo-Surgery's global endoscopy marketing group," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica. "We welcome Chris to our management team and believe his expertise will be valuable in achieving success as we look toward a selective commercial introduction for our MicroCutter product line in Europe next quarter, and, pending clearance under a 510(k) process, in the United States next year."

Mr. Littel brings more than 15 years of sales, marketing and operational experience from large and emerging medical device companies, and spent more than 15 years as a high-ranking officer in the U.S. military. Mr. Littel comes to Cardica from Neurowave Medical Technologies, Inc., where he served as vice president of marketing and business development, and was responsible for all aspects of brand strategy and marketing in addition to commercial, pipeline and other functions. Prior to Neurowave, Mr. Littel served in a variety of escalating positions at Ethicon Endo-Surgery, a division of Johnson & Johnson, most recently as the group director of global product development, endocutters. Before joining Ethicon Endo-Surgery, he served as a senior executive in the United States Army, most recently as a strategic advisor to the U.S. military representative to the North Atlantic Treaty Organization (NATO). Mr. Littel received his M.S. in international economics and international relations from Johns Hopkins University and his B.S. in engineering from the United States Military Academy at West Point.

About Cardica

Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 36,000 units throughout the world. In addition, Cardica is developing the Cardica MicroCutter XPRESS™ 30, a true multi-fire laparoscopic stapling device designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter products require 510(k) review and are not yet commercially available in the U.S. 

Forward-Looking Statements

This press release contains "forward-looking" statements, including all statements regarding the further development and commercialization of Cardica's MicroCutter product line and the potential approval of Cardica's MicroCutter products under a 510(k) process. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words and phrases "believe," "will be," "look toward," and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including that any future Cardica products face development, regulatory, reimbursement and manufacturing risks, as well as other risks detailed from time to time in Cardica's reports filed with the U.S. Securities and Exchange Commission, including its Form 10-K for the fiscal year ended June 30, 2011. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.


'/>"/>
SOURCE Cardica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011
2. Cardica Achieves Milestone Under Century Distribution Agreement
3. Cardicas Cardiac Anastomosis Device Featured in Clinical Presentation on Robotic Cardiac Bypass Procedures
4. Cardica Signs Distribution Agreement for MicroCutter in Japan
5. Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results
6. Cardica to Present at the Wedbush Life Sciences Management Access Conference
7. Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardicas Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device
8. Cardica Applies CE Mark to Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device
9. Cardica Announces Fiscal 2011 Third Quarter Financial Results
10. Cardica to Announce Fiscal 2011 Third Quarter Financial Results on Tuesday, May 10, 2011
11. Cardica Receives Key Patent for Microcutter™ Surgical Cutting and Stapling Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... -- According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - ... valued at US$ 5.89 Bn in 2014 and is anticipated ... 2023 to reach US$ 7.99 Bn in 2023. ... free drug delivery devices and the market is estimated based ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of ... Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who ... this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program ...
(Date:5/27/2016)... ... 27, 2016 , ... With over 60 percent of acute stroke survivors being ... product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been ... hemiplegia due to stroke. , Ekso Bionics has now received clearance from the U.S. ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
Breaking Medicine News(10 mins):